Manickam Kandamurugu, Donoghue Daniel J, Meyer April N, Snyder Pamela J, Prior Thomas W
Section of Human and Molecular Genetics, Nationwide Children's Hospital, Columbus, Ohio.
Am J Med Genet A. 2014 Jan;164A(1):243-50. doi: 10.1002/ajmg.a.36236. Epub 2013 Oct 29.
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is an extremely rare severe skeletal dysplasia characterized by significant developmental delay, brain structural abnormalities, hearing loss, and acanthosis nigricans. The disorder is the result of a single missense mutation at codon 650 (p.Lys650Met) in the fibroblast growth factor receptor 3 gene (FGFR3). We describe a child who initially presented with a mild achondroplasia or hypochondroplasia like phenotype. Molecular analysis of the FGFR3 gene showed the common SADDAN mutation and a second novel mutation at codon 651 (p.Thr651Pro). Both mutations were shown to occur on the same allele (cis) and de novo. Transient transfection studies with FGFR3 double mutant constructs show that the p.Thr651Pro mutation causes a dramatic decrease in constitutive receptor kinase activity than that observed by the p.Lys650Met mutation. Our data suggest that the molecular effect by the p.Thr651Pro is to elicit a conformational change that decreases the FGFR3 tyrosine kinase activity, which is constitutively activated by the SADDAN mutation. Due to the inheritance of both a gain-of-function and a loss-of-function mutation, we conclude that a reduction of constitutive activation caused the milder skeletal phenotype. Although the occurrence of double mutations are expected to be rare, the presence of other FGFR3 modifiers may be responsible for some of the clinically discrepant skeletal dysplasia cases.
伴有发育迟缓与黑棘皮症的严重软骨发育不全(SADDAN)是一种极其罕见的严重骨骼发育不良疾病,其特征为显著发育迟缓、脑结构异常、听力丧失以及黑棘皮症。该病症是由成纤维细胞生长因子受体3基因(FGFR3)第650密码子处的单个错义突变(p.Lys650Met)所致。我们描述了一名最初表现为轻度软骨发育不全或类似软骨发育低下表型的儿童。对FGFR3基因的分子分析显示存在常见的SADDAN突变以及第651密码子处的第二个新突变(p.Thr651Pro)。这两个突变均显示发生在同一等位基因上(顺式)且为新发突变。对FGFR3双突变体构建体进行的瞬时转染研究表明,与p.Lys650Met突变相比,p.Thr651Pro突变导致组成型受体激酶活性显著降低。我们的数据表明,p.Thr651Pro的分子效应是引发构象变化,从而降低FGFR3酪氨酸激酶活性,而该活性因SADDAN突变而组成型激活。由于功能获得性和功能丧失性突变的共同遗传,我们得出结论,组成型激活的降低导致了较轻的骨骼表型。尽管双突变的发生预计较为罕见,但其他FGFR3修饰因子的存在可能是一些临床骨骼发育不良差异病例的原因。